Concurrent chemotherapy and adjuvant extended field irradiation after radical surgery for cervical cancer patients with lymph node metastases

International Journal of Gynecological Cancer

Volumn 18, Issue 4, 2008, Pages 779-784

  Cheng, X ^a,b   Cai, S M ^a,b   Li, Z T ^a   Wu, X H ^a   Ding, Y Q ^a   Wang, X E ^a   Zang, R Y ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Cervical cancer; Concurrent chemotherapy; Extended field irradiation; Surgery

Indexed keywords

BLEOMYCIN; CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADENOCARCINOMA; ADULT; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; RECURRENCE RISK; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; UROGENITAL TRACT DISEASE; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RECURRENCE; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 47649131014     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01088.x     Document Type: Article

References (20)

1. Monk BJ, Cha DS, Walker JL et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph mode dissection in the treatment of stage IB and IIA cervical carcinoma. Gynecol Oncol 1994 54 : 4 9.
2. Bidus MA, Elkas JC. Cervical and vaginal cancer In : Berek JS, ed. Berek & Novak's gynecology, 14th edn. Philadelphia, PA : Lippincott Williams & Wilkins, 2007 : 1403 56.
3. Landoni F, Maneo A, Lolombo A et al. Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997 350 : 535 40.
4. Kim JH, Kim HJ, Hong S et al. Post-hysterectomy radiotherapy in FIGO stage IB-IIB uterine cervical carcinoma. Gynecol Oncol 2005 96 : 407 14.
5. Rotman M, Pajak TF, Choi K et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 1995 274 : 427 8.
6. Haie C, Pejovic MH, Gerbaulet A et al. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC Radiotherapy Group. Radiother Oncol 1988 11 : 101 12.
7. Cheng X, Cai SM, Li ZT et al. The prognosis of women with stage IB1-IIB node-positive cervical carcinoma after radical surgery. World J Surg Oncol 2004 18 : 47.
8. Varia MA, Bundy BN, Deppe G et al. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1998 42 : 1015 23.
9. Sood BM, Gorla GR, Garg M et al. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix. Clinical experience with and without concomitant chemotherapy. Cancer 2003 97 : 1781 8.
10. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995 31 : 1341 6.
11. Jermal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007 57 : 43 66.
12. Morbidity of malignant tumors in Shanghai in 2003. Tumor 2006 26 : 694.
13. Kim JS, Kim JS, Kim SY et al. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2003 55 : 1247 53.
14. Small W, Winter K, Levenback C et al. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys 2007 68 : 1081 7.
15. Eifel PJ, Winter K, Morris M et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol 2004 22 : 872 80.
16. Malfetano JH, Keys H, Cunningham MJ et al. Extended field radiation and cisplatin for stage IIB and IIIB cervical carcinoma. Gynecol Oncol 1997 67 : 203 7.
17. Long HJ. Management of metastatic cervical cancer: review of the literature. J Clin Oncol 2007 25 : 2966 74.
18. Gerszten K, Colonello K, Heron DE et al. Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. Gynecol Oncol 2006 102 : 182 8.
19. Salama JK, Mundt AJ, Roeske J et al. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 2006 65 : 1170 6.
20. Beriwal S, Gan GN, Heron DE et al. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2007 68 : 166 71.